0R44 Stock Overview
Develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
C-Rad AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 29.85 |
| 52 Week High | SEK 49.20 |
| 52 Week Low | SEK 28.70 |
| Beta | 0.91 |
| 1 Month Change | 2.75% |
| 3 Month Change | n/a |
| 1 Year Change | -22.57% |
| 3 Year Change | -41.93% |
| 5 Year Change | -26.66% |
| Change since IPO | -11.16% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0R44 | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -0.02% | 0.9% |
| 1Y | -22.6% | 0.05% | 0.3% |
Return vs Industry: 0R44 underperformed the UK Medical Equipment industry which returned 1.5% over the past year.
Return vs Market: 0R44 underperformed the UK Market which returned 1.1% over the past year.
Price Volatility
| 0R44 volatility | |
|---|---|
| 0R44 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.2% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in GB Market | 10.9% |
| 10% least volatile stocks in GB Market | 3.1% |
Stable Share Price: 0R44's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0R44's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 99 | Cecilia de Leeuw | www.c-rad.com |
C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company’s products include Sentinel 4DCT, a laser-based optical surface scanning system; Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a surface image guided radiation therapy solution that supports proton therapy from simulation to treatment; and Catalyst+ HD Ring Gantry solution for patient positioning, real-time motion monitoring, and respiratory gating. It provides Catalyst, a 4D surface guided radiation therapy (SGRT) solution; Catalyst HD, a SGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst PT, a tracking solution for particle therapy; and visual coaching solutions used for prospective and retrospective radiotherapy.
C-Rad AB (publ) Fundamentals Summary
| 0R44 fundamental statistics | |
|---|---|
| Market cap | SEK 1.02b |
| Earnings (TTM) | SEK 32.25m |
| Revenue (TTM) | SEK 469.80m |
31.6x
P/E Ratio2.2x
P/S RatioIs 0R44 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0R44 income statement (TTM) | |
|---|---|
| Revenue | SEK 469.80m |
| Cost of Revenue | SEK 145.00m |
| Gross Profit | SEK 324.80m |
| Other Expenses | SEK 292.55m |
| Earnings | SEK 32.25m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Jul 18, 2025
| Earnings per share (EPS) | 0.96 |
| Gross Margin | 69.14% |
| Net Profit Margin | 6.86% |
| Debt/Equity Ratio | 0% |
How did 0R44 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/08 23:54 |
| End of Day Share Price | 2025/04/25 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
C-Rad AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Victor Forssell | ABG Sundal Collier Sponsored |
| Christian Lee | Pareto Securities |